WHO Expert Committee on Biological Standardization: seventy-seventh report
Cited by World Health Organization on
The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.
Regulatory Aspects of Gene Therapy and Cell Therapy Products
Overview of attention for book
Table of Contents
-
Altmetric BadgeBook Overview
-
Altmetric BadgeChapter 1 United States Food and Drug Administration Regulation of Gene and Cell Therapies
-
Altmetric BadgeChapter 2 The National Institutes of Health Oversight of Human Gene Transfer Research: Enhancing Science and Safety
-
Altmetric BadgeChapter 3 Regulatory Oversight of Cell and Gene Therapy Products in Canada
-
Altmetric BadgeChapter 4 Overview of the Regulatory Oversight Implemented by the French Regulatory Authorities for the Clinical Investigation of Gene Therapy and Cell Therapy Products
-
Altmetric BadgeChapter 5 Regulation of Clinical Trials with Advanced Therapy Medicinal Products in Germany
-
Altmetric BadgeChapter 6 Marketing Regulatory Oversight of Advanced Therapy Medicinal Products (ATMPs) in Europe: The EMA/CAT Perspective.
-
Altmetric BadgeChapter 7 Requirements for Clinical Trials with Gene Therapy and Transplant Products in Switzerland
-
Altmetric BadgeChapter 8 Regulatory Frameworks for Gene and Cell Therapies in Japan
-
Altmetric BadgeChapter 9 Regulatory Oversight of Gene Therapy and Cell Therapy Products in Korea
-
Altmetric BadgeChapter 10 Regulation of Cell and Gene Therapy Medicinal Products in Taiwan
-
Altmetric BadgeChapter 11 Regulatory Oversight of Cell- and Tissue-Based Therapeutic Products and Gene Therapy Products in Singapore
-
Altmetric BadgeChapter 12 The Regulatory Pathway for Advanced Cell Therapy and Gene Therapy Products in Brazil: A Road to Be Built
